Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Envista Holdings Corporation (NVST : NYSE)
 
 • Company Description   
Envista Holdings Corporation manufactures and sells dental products primarily in the United States and internationally. The company's Specialty Products & Technologies segment provides dental implant systems, guided surgery systems, biomaterials, prefabricated and custom-built prosthetics and dental eye loupes to oral surgeons, prosthodontists and periodontists; Equipment & Consumables segment develops, manufactures and markets dental equipment and supplies used in dental offices, including digital imaging systems, software and other visualization/magnification systems; handpieces and associated consumables; treatment units and other dental practice equipment; endodontic systems and related consumables; restorative materials and instruments, rotary burs, impression materials, bonding agents and cements and infection prevention products. Envista Holdings Corporation is based in Brea, California.

Number of Employees: 12,300

 
 • Price / Volume Information   
Yesterday's Closing Price: $20.72 Daily Weekly Monthly
20 Day Moving Average: 1,785,931 shares
Shares Outstanding: 169.49 (millions)
Market Capitalization: $3,511.77 (millions)
Beta: 1.00
52 Week High: $23.00
52 Week Low: $14.22
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 9.80% 5.69%
12 Week 36.49% 14.81%
Year To Date 7.41% 0.59%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
200 S. KRAEMER BLVD. BUILDING E
-
BREA,CA 92821
USA
ph: 714-817-7000
fax: 714-817-5450
ir@envistaco.com http://www.envistaco.com
 
 • General Corporate Information   
Officers
Paul Keel - President; Chief Executive Officer
Scott Huennekens - Chairman
Eric Hammes - Senior Vice President and Chief Financial Officer
Faez Kaabi - Vice President and Chief Accounting Officer
Wendy Carruthers - Director

Peer Information
Envista Holdings Corporation (BJCT)
Envista Holdings Corporation (CADMQ)
Envista Holdings Corporation (APNO)
Envista Holdings Corporation (UPDC)
Envista Holdings Corporation (IMTIQ)
Envista Holdings Corporation (CYGN)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED PRODUCTS
Sector: Medical
CUSIP: 29415F104
SIC: 3843
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/25
Next Expected EPS Date: 07/31/25
Share - Related Items
Shares Outstanding: 169.49
Most Recent Split Date: (:1)
Beta: 1.00
Market Capitalization: $3,511.77 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $0.25 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $1.03 Payout Ratio: 0.00
Number of Estimates in the Fiscal Year Consensus: 8.00 Change In Payout Ratio: 0.00
Estmated Long-Term EPS Growth Rate: 15.30% Last Dividend Paid: NA - $0.00
Next EPS Report Date: 07/31/25  
 

 • Fundamental Ratios
P/E
Current FY Estimate: 20.14
Trailing 12 Months: 29.18
PEG Ratio: 1.32
Price Ratios
Price/Book: 1.16
Price/Cash Flow: 12.47
Price / Sales: 1.40
EPS Growth
vs. Year Ago Period: -7.69%
vs. Previous Quarter: 0.00%
Sales Growth
vs. Year Ago Period: -1.07%
vs. Previous Quarter: -5.51%
ROE
06/30/25 - -
03/31/25 - 4.07
12/31/24 - 3.86
ROA
06/30/25 - -
03/31/25 - 2.25
12/31/24 - 2.21
Current Ratio
06/30/25 - -
03/31/25 - 2.12
12/31/24 - 2.04
Quick Ratio
06/30/25 - -
03/31/25 - 1.82
12/31/24 - 1.76
Operating Margin
06/30/25 - -
03/31/25 - 4.88
12/31/24 - 5.04
Net Margin
06/30/25 - -
03/31/25 - -44.90
12/31/24 - -44.56
Pre-Tax Margin
06/30/25 - -
03/31/25 - -43.57
12/31/24 - -43.21
Book Value
06/30/25 - -
03/31/25 - 17.91
12/31/24 - 17.05
Inventory Turnover
06/30/25 - -
03/31/25 - 4.46
12/31/24 - 4.39
Debt-to-Equity
06/30/25 - -
03/31/25 - 0.43
12/31/24 - 0.44
Debt-to-Capital
06/30/25 - -
03/31/25 - 29.91
12/31/24 - 30.34
 

Powered by Zacks Investment Research ©